Go to Client Portal

Alternative Test Methods for Medical Device Sterilization Validation: An Industry Panel Discussion



May 20, 2021

Access On-Demand Webinar Here.

Utilizing alternative sterilization validation methods can not only save time and money when developing new medical devices, but they can also provide an excellent business continuity plan.

However, the U.S. Food and Drug Administration (FDA) has increased scrutiny on the use of newer, alternative sterilization methods (i.e. flexible chamber EtO) and lesser-known methods such as H2O2 and ClO2. This has proven to be challenging for several medical device manufacturers as they plan for regulatory submissions and approvals.

Join NAMSA, alongside a panel of medtech industry experts, for a virtual discussion focused on the use of alternative sterilization validation methods and strategies and best practices regarding how to mitigate risk of when employing these test methods in regulatory submissions.

Attendees can expect to gain a better understanding on:

  • Novel sterilization methods and their key features and limitations
  • How to evaluate the regulatory risks of using novel sterilization methods
  • The availability and logistical implications of using on-site vs. off-site sterilization systems

Who Should Attend: Regulatory Professionals, R&D Professionals, VPs and Directors of Regulatory, Sterilization Managers and Quality
Control Managers


*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebcast, to host NAMSA webinars. For information related to GoToWebcast’s privacy policy and utilization of information, please contact GoToWebcast directly.


Kirk Honour

Principal Consultant - Product Development Strategy

Kirk Honour has been involved in the MedTech industry for more than 25 years, bringing products from concept to commercialization. He is the Founder of YapStone Inc. and Co-Founder EVO Transportation & Energy Services.

Ted May

President & CEO, Andersen Products, Inc.

Ted May has more than 20 years of experience in the field of infection control, and more than 35 years of experience in international business and trade promotion—both with private companies and at the Federal and State levels.

Nicole Williams

Director of Commercialization, Sterilucent, Inc.

Nicole Williams has more than 22 years of experience in the medical device industry, ranging from low temperature sterilization, medical device development and clinical and regulatory affairs.

Paul Lorcheim

Director of Operations, ClorDiSys Solutions

Paul Lorcheim has been a part of the pharmaceutical industry for more than 40 years. He has been with ClorDiSys Solutions, Inc. since 2001 as Director of Operations directing the implementation, commercialization and manufacturing of various decontaminating and sterilization equipment for the pharmaceutical, life science and food industry.